August 20, 2010 -- Sinopharm Group will locate its antibiotic manufacturing center in Datong City, Shanxi province, at a facility it acquired as part of the purchase of Shandong Weiqida Pharma. Sinopharm is also reorganizing Aurobindo (Datong) Biopharma and will presumably move its antibiotic production into the Weiqida plant. More details... Stock Symbols: (HKEX: 01099)
